SCHEMBL25754075

SCHEMBL25754075

COC(=O)C[C@H](NC(=O)CN)c1cc(C)cc(Cl)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WDR5 P61964 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
POLB P06746 3/20 0.35
ITGB3 P05106 2/20 0.35
ITGAV P06756 2/20 0.35
ITGB5 P18084 2/20 0.35
ITGB6 P18564 2/20 0.35
LMNA P02545 2/20 0.35
ITGB1 P05556 1/20 0.35
ITGA5 P08648 1/20 0.35
ITGB8 P26012 1/20 0.35
ITGA8 P53708 1/20 0.35
MAPT P10636 1/20 0.34
TP53 P04637 1/20 0.33
THRB P10828 1/20 0.33
PNP P00491 1/20 0.33
KMT2A Q03164 2/20 0.33
TACR3 P29371 1/20 0.33
ALDH1A1 P00352 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24036755 0.92 L3MBTL1 (0.42) WDR5L3MBTL1POLBITGB3ITGAV
SCHEMBL24036565 0.87 WDR5 (0.37) WDR5L3MBTL1POLBITGB3ITGAV
SCHEMBL24036756 0.86 POLB (0.38) WDR5L3MBTL1POLBITGB3ITGAV
SCHEMBL25754069 0.85 POLB (0.39) L3MBTL1POLBITGB3ITGAVITGB5
SCHEMBL25754000 0.83 ITGB3 (0.37) WDR5L3MBTL1ITGB3ITGAVITGB5
SCHEMBL25625380 0.82 WDR5 (0.35) WDR5L3MBTL1POLBLMNAITGB1
Hydrochloric Acid SCHEMBL30388430 0.82 ITGB3 (0.37) WDR5L3MBTL1ITGB3ITGAVITGB5
SCHEMBL24036731 0.82 WDR5 (0.50) WDR5PNPKMT2ATACR3ALDH1A1
SCHEMBL25625085 0.81 THRB (0.36) POLBITGB3ITGAVITGB5ITGB6
SCHEMBL24036821 0.81 ITGB1 (0.40) WDR5ITGB3ITGAVITGB5ITGB6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192661-A1 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE UBE CORPORATION (JP) 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192661-A1 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE DHFR, DPYD, CYP2D6 WDR5 2145/4885L3MBTL1 2036/4885POLB 860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.